Recruiting PHASE1 INTERVENTIONAL 2-arm
NCT06942104
Imaging of Solid Tumors Using 18F-TRX
Sponsor: Rahul Aggarwal
Conditions
Castration-Resistant Prostate Carcinoma Glioma, Malignant Locally Advanced Clear Cell Renal Cell Carcinoma Metastatic Clear Cell Renal Cell Carcinoma Metastatic Malignant Solid Neoplasm Solid Carcinoma Solid Tumor Stage III Renal Cell Cancer AJCC v8 Stage IV Renal Cell Cancer AJCC v8 Stage IVB Prostate Cancer AJCC v8
Interventions
18F-TRX Blood Specimen Collection Positron Emission Tomography (PET)/Computerized tomography (CT) Tumor Biopsy
Updated 2 times since 2025 Last updated: Jul 17, 2025 Started: Jul 3, 2025 Primary completion: Sep 30, 2026 Completion: Sep 30, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT06942104, this PHASE1 trial focuses on Castration-Resistant Prostate Carcinoma and Glioma, Malignant and remains actively recruiting participants. Sponsored by Rahul Aggarwal, it has been updated 2 times since 2025, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
2 versions recorded-
Aug 2025 — Present [monthly]
Recruiting PHASE1
Status: Not Yet Recruiting → Recruiting
-
May 2025 — Aug 2025 [monthly]
Not Yet Recruiting PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Rahul Aggarwal
- United States Department of Defense
Data source: University of California, San Francisco
For direct contact, visit the study record on ClinicalTrials.gov .